The Importance of Clinical Trials in Infertility

Now Viewing

EP: 1.The Importance of Clinical Trials in Infertility

EP: 2.Coverage Considerations for ART Protocols

EP: 3.Overcoming Barriers in ART

EP: 4.Characteristics of a Comprehensive ART Program

EP: 5.Incorporating Social Determinants of Health in ART

EP: 6.Best Practices in Communicating the Benefits of ART

EP: 7.The Role of Quality, Benchmarking and KPIs in ART Decision-Making

EP: 8.Addressing Unmet Needs in ART

EP: 9.Key Clinical Information on Infertility

EP: 10.Association of Infertility and Mental Health

EP: 11. Innovations in Assisted Reproductive Technologies for Women

EP: 12.Impact of Infertility on Partners

EP: 13.Examining the History of IVF

EP: 14.Future Modalities for Infertility

EP: 15.Background of Assisted Reproductive Technology

EP: 16.Describing Intrauterine Induction and Target Patient Populations

EP: 17.Exploring Best Practices for IVF

EP: 18.Examining the Role of Intracytoplasmic Sperm Injection

EP: 19.Discussing Treatments to Stimulate Ovulation

EP: 20.Role of Different Progesterone Injections in Leading to Successful Pregnancies

EP: 21.Key Clinical Considerations for Unique Patient Populations

Video content above is prompted by the following:

• Why is it necessary to have comparison trials for the different assisted reproductive technologies (ARTs) that are used in clinical practice?
• What was seen in the trial that compared highly purified human menotropin (HP-hMG) and recombinant follicle-stimulating hormone (FSH), and how do these results affect your decision-making?
• What was seen in a study that examined health benefit design for ART and its impact on pregnancy outcomes?